Enliven Therapeutics, Inc. (ELVN)

Every official Enliven Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Enliven Therapeutics, Inc. documents

• Enliven Therapeutics, Inc. 10-K 2026ELVN 10-K 2026: annual report for fiscal 2026
• Enliven Therapeutics, Inc. 10-K 2025ELVN 10-K 2025: annual report for fiscal 2025
• Enliven Therapeutics, Inc. 10-K 2024ELVN 10-K 2024: annual report for fiscal 2024
• Enliven Therapeutics, Inc. 10-K 2023ELVN 10-K 2023: annual report for fiscal 2023
• Enliven Therapeutics, Inc. 10-K 2022ELVN 10-K 2022: annual report for fiscal 2022
• Enliven Therapeutics, Inc. 10-Q 2026ELVN 10-Q 2026: quarterly report for fiscal 2026
• Enliven Therapeutics, Inc. 10-Q 2025ELVN 10-Q 2025: quarterly report for fiscal 2025
• Enliven Therapeutics, Inc. 10-Q 2024ELVN 10-Q 2024: quarterly report for fiscal 2024
• Enliven Therapeutics, Inc. 10-Q 2023ELVN 10-Q 2023: quarterly report for fiscal 2023
• Enliven Therapeutics, Inc. 10-Q 2022ELVN 10-Q 2022: quarterly report for fiscal 2022
• Enliven Therapeutics, Inc. 8-K 2026ELVN 8-K 2026: current report for fiscal 2026
• Enliven Therapeutics, Inc. 8-K 2025ELVN 8-K 2025: current report for fiscal 2025
• Enliven Therapeutics, Inc. 8-K 2024ELVN 8-K 2024: current report for fiscal 2024
• Enliven Therapeutics, Inc. 8-K 2023ELVN 8-K 2023: current report for fiscal 2023
• Enliven Therapeutics, Inc. 8-K 2022ELVN 8-K 2022: current report for fiscal 2022
• Enliven Therapeutics, Inc. DEF 14A 2026ELVN DEF 14A 2026: proxy statement for fiscal 2026
• Enliven Therapeutics, Inc. DEF 14A 2025ELVN DEF 14A 2025: proxy statement for fiscal 2025
• Enliven Therapeutics, Inc. DEF 14A 2024ELVN DEF 14A 2024: proxy statement for fiscal 2024
• Enliven Therapeutics, Inc. DEF 14A 2023ELVN DEF 14A 2023: proxy statement for fiscal 2023
• Enliven Therapeutics, Inc. DEF 14A 2022ELVN DEF 14A 2022: proxy statement for fiscal 2022
• Enliven Therapeutics, Inc. Form 4 2026ELVN Form 4 2026: insider trading filing for fiscal 2026
• Enliven Therapeutics, Inc. Form 4 2025ELVN Form 4 2025: insider trading filing for fiscal 2025
• Enliven Therapeutics, Inc. Form 4 2024ELVN Form 4 2024: insider trading filing for fiscal 2024
• Enliven Therapeutics, Inc. Form 4 2023ELVN Form 4 2023: insider trading filing for fiscal 2023
• Enliven Therapeutics, Inc. Form 4 2022ELVN Form 4 2022: insider trading filing for fiscal 2022
• Enliven Therapeutics, Inc. S-1 2026ELVN S-1 2026: registration statement for fiscal 2026
• Enliven Therapeutics, Inc. S-1 2025ELVN S-1 2025: registration statement for fiscal 2025
• Enliven Therapeutics, Inc. S-1 2024ELVN S-1 2024: registration statement for fiscal 2024
• Enliven Therapeutics, Inc. S-1 2023ELVN S-1 2023: registration statement for fiscal 2023
• Enliven Therapeutics, Inc. S-1 2022ELVN S-1 2022: registration statement for fiscal 2022
• Enliven Therapeutics, Inc. 13F 2026ELVN 13F 2026: institutional holdings for fiscal 2026
• Enliven Therapeutics, Inc. 13F 2025ELVN 13F 2025: institutional holdings for fiscal 2025
• Enliven Therapeutics, Inc. 13F 2024ELVN 13F 2024: institutional holdings for fiscal 2024
• Enliven Therapeutics, Inc. 13F 2023ELVN 13F 2023: institutional holdings for fiscal 2023
• Enliven Therapeutics, Inc. 13F 2022ELVN 13F 2022: institutional holdings for fiscal 2022

More companies